Proteostasis Ther (PTI) Stock News
NYSE:PTI - New York Stock Exchange, Inc. -
PTI Latest News, Press Relases and Analysis
Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Reverse Stock Split Ratio
Technical Short Put Spread Fade the Dip Trade and Trigger in Proteostasis Therapeutics Inc
The Techncial Trigger Driven Option Trade Right Before Proteostasis Therapeutics Inc (NASDAQ:PTI) Earnings.
The Exact Trigger that Indicates Volatility in Proteostasis Therapeutics Inc
The Trigger That Turned Proteostasis Therapeutics Inc (NASDAQ:PTI) Volatility into a Winner.
Proteostasis Therapeutics Reports Third Quarter 2020 Financial Results
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers Aurora Cannabis (NYSE:ACB) stock rose 20.99% to $5.36 during Thursday's pre-market session. The company's market cap stands at $603.3 million. Tilray (...
Proteostasis Therapeutics (PTI) Sees Hammer Chart Pattern: Time to Buy?
Proteostasis Therapeutics (PTI) has been struggling lately, but the selling pressure may be coming to an end soon.
Forget Bargain Hunting: Play 5 Stocks With Rising P/E
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – GLIBA, PTI, MR, CBMG
NEW YORK, NY / ACCESSWIRE / October 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: GCI Liberty, Inc. (NASDAQ:GLIBA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Liberty Broadband Corporation. Visit our website to learn more and participate in an action:
SHAREHOLDER ALERT: WeissLaw LLP Reminds PTI and NETE Shareholders About Its Ongoing Investigations
Mentions: NETE
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – SBPH, GLIBA, CBMG, PTI
NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its proposed merger with F-star Therapeutics, Limited. Under the terms of the share exchange agreement, Spring Bank will acquire all of the outstanding share
WeissLaw LLP Reminds BYFC, OTEL and PTI Shareholders About Its Ongoing Investigations
Mentions: BYFC
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – AIMT, AKCA, PTI
NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Aimmune Therapeutics, Inc. (NASDAQ:AIMT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sociétés des Produits Nestlé, S.A. for $34.50 per share. To learn more about your legal rights and options, visit:
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, VAR, PTI, LVGO
NEW YORK, NY / ACCESSWIRE / September 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sanofi for $100 per share. To learn more about your legal rights and options, visit:
SHAREHOLDER ALERT: WeissLaw LLP Reminds PTI and TRNE Shareholders About Its Ongoing Investigations
Mentions: TRNE
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PTI, CGIX, BYFC, BLDR
NEW YORK, NY / ACCESSWIRE / September 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Proteostasis Therapeutics, Inc. (NASDAQ: PTI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Yumanity Therapeutics. Under the terms of the merger agreement, Proteostasis will acquire all outstanding shares of Yumanity in exchange for
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, MNTA, PTI, BLDR
NEW YORK, NY / ACCESSWIRE / August 29, 2020 /Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sanofi for $100 per share. To learn more about your legal rights and options, visit:
STOCKHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Proteostasis Therapeutics, Inc. - PTI
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – CBMG, PRNB, MNTA, PTI
NEW YORK, NY / ACCESSWIRE / August 25, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. Under the terms of the merger, Cellular Biomedicine